Harvard Bioscience, Inc. (HBIO) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.67 +8.10%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $29.2 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
